Vaccine Trials, Pediatric Clinical and Translational Research Unit
Vaccine Trials Unit Mission:
Addressing health inequities through safe and effective vaccine development/trials with a focus on emerging infections, HIV, and other vaccine preventable conditions.
Pediatric Clinical & Translational Research Unit Mission:
Leading innovative clinical and translational research to improve the health and well-being of all children, with emphasis on minority and medically underserved children in Georgia, US, and worldwide.
MSM COVID 19 Vaccine Trial Interest Survey
Please fill out the survey if you are interested and be a part of the changing face of research in this diverse community.
HUMMINGBIRD Pediatric COVID-19 Vaccine Study
Morehouse School of Medicine is participating in a new clinical trial called the HUMMINGBIRD study, a Phase 2/3 study to evaluate the safety and immunogenicity of an investigational vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 in pediatric participants.
Combating Antibiotic Resistance Through Education (Project HIRaCAARI)
Our goal is to empower high-risk communities to stop the spread of antibiotic resistant MRSA and other Skin and Soft Tissue Infections (SSTI). This will be accomplished through the strengthened abilities of public, school, and academic librarians, school nurses and athletic staff, and others to support their community members in the use of the NLM databases to address the growing health disparity seen with antibiotic resistant infections in our communities.
Novavax
This is a research study of an investigational vaccine made by Novavax, Inc. called “SARS-CoV-2 rS with Matrix-M1™ Adjuvant”. The study is a multicenter, global study with countries selected based on the expected COVID-19 epidemiology and healthcare system characteristics. The objectives are to determine whether the vaccine prevents COVID-19 disease, to see if the study vaccine continues to be safe for people to use, and whether it may cause side effects, and to see what different types of immune responses are stimulated by the study vaccine.
Further Unit Studies
- CoVPN 3006
- GSK Lullaby Study
- Nutritional Cookie Supplement for SCD
- Childhood Lead Exposure Study
- MRSA ED Study
- Data Science Projects/GIS
Vaccine Trials, Pediatric Clinical and Translational Research Unit Team
Erica L. Johnson, Ph.D
Associate Professor of Microbiology, Biochemistry & Immunology / Obstetrics & Gynecology, Translational Research Scientist, Co-Director of MSM Vaccine Trials Unit and Pediatric Clinical Translational Research Unit
Austin W. Chan, M.D.
Assistant Professor of Medicine, Principal Investigator GAETC
Norberto Fas, MD, MBA, FACP, CPE
Associate Professor Internal Medicine, Office of the Dean and VP for Healthcare and Academic Affairs
LaKesha Tables, M.D., MPH
Assistant Professor of Community Health & Preventive Medicine